Impaired hypoglycemia awareness in diabetes: epidemiology, mechanisms and therapeutic approaches

Impaired awareness of hypoglycemia (IAH) is a frequent complication of insulin therapy. Up to half insulin-treated individuals with type 1 and type 2 diabetes report the problems with hypoglycemia awareness, and 15–25% of patients have a permanent IAH. A recurrent hypoglycemia is a corner...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autor principal: Vadim V. Klimontov
Formato: article
Lenguaje:EN
RU
Publicado: Endocrinology Research Centre 2018
Materias:
Acceso en línea:https://doaj.org/article/e32ac47ad9914153837ee287380fec78
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:e32ac47ad9914153837ee287380fec78
record_format dspace
spelling oai:doaj.org-article:e32ac47ad9914153837ee287380fec782021-11-14T09:00:22ZImpaired hypoglycemia awareness in diabetes: epidemiology, mechanisms and therapeutic approaches2072-03512072-037810.14341/DM9597https://doaj.org/article/e32ac47ad9914153837ee287380fec782018-12-01T00:00:00Zhttps://www.dia-endojournals.ru/jour/article/view/9597https://doaj.org/toc/2072-0351https://doaj.org/toc/2072-0378Impaired awareness of hypoglycemia (IAH) is a frequent complication of insulin therapy. Up to half insulin-treated individuals with type 1 and type 2 diabetes report the problems with hypoglycemia awareness, and 15–25% of patients have a permanent IAH. A recurrent hypoglycemia is a cornerstone in IAH formation. The repeated episodes of hypoglycemia impair neurohumoral response to hypoglycemia, reduce its symptoms and induce inadequate brain adaptation to low glucose levels. In this regard, the IAH phenomenon can be considered as an example of "metabolic memory" in diabetes. The IAH is associated with episodes of severe hypoglycemia, fear of hypoglycemia and cognitive dysfunction. These associates can be combined into IAH syndrome. Development of IAH becomes a serious barrier in diabetes management. A growing body of evidence indicates that IAH is a reversible condition. If the syndrome is present, the hypoglycemia avoidance should be primary goal of the treatment. Structured training under specialized programs with psychological support is the most reasonable therapeutic approach to IAH amending. Technological approaches, including continuous subcutaneous insulin infusion, real-time continuous glucose monitoring, closed-loop insulin delivery systems ("artificial pancreas"), and islet transplantation also showed efficacy in hypoglycemia awareness improvement in some clinical studies. The diabetes management in patients with IAH is time-consuming and expensive. Therefore, step-by-step approach, from insulin personalization and therapeutic training to advanced medical technologies, should be recommended for these patients.Vadim V. KlimontovEndocrinology Research CentrearticlediabeteshypoglycemiainsulinbrainglucoseNutritional diseases. Deficiency diseasesRC620-627ENRUСахарный диабет, Vol 21, Iss 6, Pp 513-523 (2018)
institution DOAJ
collection DOAJ
language EN
RU
topic diabetes
hypoglycemia
insulin
brain
glucose
Nutritional diseases. Deficiency diseases
RC620-627
spellingShingle diabetes
hypoglycemia
insulin
brain
glucose
Nutritional diseases. Deficiency diseases
RC620-627
Vadim V. Klimontov
Impaired hypoglycemia awareness in diabetes: epidemiology, mechanisms and therapeutic approaches
description Impaired awareness of hypoglycemia (IAH) is a frequent complication of insulin therapy. Up to half insulin-treated individuals with type 1 and type 2 diabetes report the problems with hypoglycemia awareness, and 15–25% of patients have a permanent IAH. A recurrent hypoglycemia is a cornerstone in IAH formation. The repeated episodes of hypoglycemia impair neurohumoral response to hypoglycemia, reduce its symptoms and induce inadequate brain adaptation to low glucose levels. In this regard, the IAH phenomenon can be considered as an example of "metabolic memory" in diabetes. The IAH is associated with episodes of severe hypoglycemia, fear of hypoglycemia and cognitive dysfunction. These associates can be combined into IAH syndrome. Development of IAH becomes a serious barrier in diabetes management. A growing body of evidence indicates that IAH is a reversible condition. If the syndrome is present, the hypoglycemia avoidance should be primary goal of the treatment. Structured training under specialized programs with psychological support is the most reasonable therapeutic approach to IAH amending. Technological approaches, including continuous subcutaneous insulin infusion, real-time continuous glucose monitoring, closed-loop insulin delivery systems ("artificial pancreas"), and islet transplantation also showed efficacy in hypoglycemia awareness improvement in some clinical studies. The diabetes management in patients with IAH is time-consuming and expensive. Therefore, step-by-step approach, from insulin personalization and therapeutic training to advanced medical technologies, should be recommended for these patients.
format article
author Vadim V. Klimontov
author_facet Vadim V. Klimontov
author_sort Vadim V. Klimontov
title Impaired hypoglycemia awareness in diabetes: epidemiology, mechanisms and therapeutic approaches
title_short Impaired hypoglycemia awareness in diabetes: epidemiology, mechanisms and therapeutic approaches
title_full Impaired hypoglycemia awareness in diabetes: epidemiology, mechanisms and therapeutic approaches
title_fullStr Impaired hypoglycemia awareness in diabetes: epidemiology, mechanisms and therapeutic approaches
title_full_unstemmed Impaired hypoglycemia awareness in diabetes: epidemiology, mechanisms and therapeutic approaches
title_sort impaired hypoglycemia awareness in diabetes: epidemiology, mechanisms and therapeutic approaches
publisher Endocrinology Research Centre
publishDate 2018
url https://doaj.org/article/e32ac47ad9914153837ee287380fec78
work_keys_str_mv AT vadimvklimontov impairedhypoglycemiaawarenessindiabetesepidemiologymechanismsandtherapeuticapproaches
_version_ 1718429497712181248